{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:09Z","timestamp":1740107649683,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00467-017-3578-7","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T08:04:17Z","timestamp":1486973057000},"page":"721-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics?"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5878-941X","authenticated-orcid":false,"given":"Detlef","family":"Bockenhauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"3578_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MNH.0b013e3283436f14","volume":"20","author":"EA Elhassan","year":"2011","unstructured":"Elhassan EA, Schrier RW (2011) Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists. Curr Opin Nephrol Hypertens 20:161\u2013168","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3578_CR2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","volume":"385","author":"AC Ong","year":"2015","unstructured":"Ong AC, Devuyst O, Knebelmann B, Walz G, Diseases E-EWGIK (2015) Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet 385:1993\u20132002","journal-title":"Lancet"},{"key":"3578_CR3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","volume":"1812","author":"S Terryn","year":"2011","unstructured":"Terryn S, Ho A, Beauwens R, Devuyst O (2011) Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease. Biochim Biophys Acta 1812:1314\u20131321","journal-title":"Biochim Biophys Acta"},{"key":"3578_CR4","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, Investigators TT (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407\u20132418","journal-title":"N Engl J Med"},{"key":"3578_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/apa.13697","author":"S Dufek","year":"2016","unstructured":"Dufek S, Booth C, Carroll A, Van\u2019t Hoff W, Kleta R, Bockenhauer D (2016) Urea is successful in treating inappropriate antidiuretic hormone secretion in an infant. Acta Paediatr. doi: 10.1111\/apa.13697","journal-title":"Acta Paediatr"},{"key":"3578_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3584-9","author":"RD Gilbert","year":"2017","unstructured":"Gilbert RD, Evans H, Olalekan K, Nagra A, Haq MR, Griffiths M (2017) Tolvaptan treatment for severe, neonatal, autosomal dominant polycystic kidney disease. Pediatr Nephrol. doi: 10.1007\/s00467-017-3584-9","journal-title":"Pediatr Nephrol"},{"key":"3578_CR7","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/archdischild-2016-311535.61","volume":"101","author":"K Olalekan","year":"2016","unstructured":"Olalekan K, Fox A, Gilbert R (2016) Tolvaptan use in severe neonatal autosomal dominant polycystic kidney disease (ADPKD): The pharmaceutical challenge. Arch Dis Child 101:e2","journal-title":"Arch Dis Child"},{"key":"3578_CR8","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-013-2484-x","volume":"28","author":"RD Gilbert","year":"2013","unstructured":"Gilbert RD, Sukhtankar P, Lachlan K, Fowler DJ (2013) Bilineal inheritance of PKD1 abnormalities mimicking autosomal recessive polycystic disease. Pediatr Nephrol 28:2217\u20132220","journal-title":"Pediatr Nephrol"},{"key":"3578_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpeds.2014.06.015","volume":"165","author":"LM Guay-Woodford","year":"2014","unstructured":"Guay-Woodford LM, Bissler JJ, Braun MC, Bockenhauer D, Cadnapaphornchai MA, Dell KM, Kerecuk L, Liebau MC, Alonso-Peclet MH, Shneider B, Emre S, Heller T, Kamath BM, Murray KF, Moise K, Eichenwald EE, Evans J, Keller RL, Wilkins-Haug L, Bergmann C, Gunay-Aygun M, Hooper SR, Hardy KK, Hartung EA, Streisand R, Perrone R, Moxey-Mims M (2014) Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J Pediatr 165:611\u2013617","journal-title":"J Pediatr"},{"key":"3578_CR10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.11311111","volume":"7","author":"D Zittema","year":"2012","unstructured":"Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT (2012) Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin J Am Soc Nephrol 7:906\u2013913","journal-title":"Clin J Am Soc Nephrol"},{"key":"3578_CR11","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/apa.13415","volume":"105","author":"D Marx-Berger","year":"2016","unstructured":"Marx-Berger D, Milford DV, Bandhakavi M, Van\u2019t Hoff W, Kleta R, Dattani M, Bockenhauer D (2016) Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants. Acta Paediatr 105:e334\u2013337","journal-title":"Acta Paediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3578-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:24:15Z","timestamp":1498371855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3578-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}